miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


Fairfield Market Research unveils insights into the thriving miRNA Sequencing and Assay Market

Fairfield Market Research, a leading market analysis firm, has released its latest report on the miRNA Sequencing and Assay Market, showcasing remarkable growth potential and factors driving its expansion. In 2024, the global market reached US$ 343 million in sales, and the market is set to scale new heights.

Sequencing by Synthesis Takes the Lead

Sequencing by Synthesis is anticipated to be the highest revenue-generating technology category from 2024 to 2031. This highlights the critical role of technological advancements in driving the miRNA Sequencing and Assay Market forward.

Driving Forces for miRNA Sequencing and Assay Demand

The market's growth is propelled by several key factors, including:

1. Increase in Infectious and Communicable Illnesses: A surge in the frequency of infectious diseases has intensified the need for accurate miRNA sequencing and assays for diagnosis and treatment.

2. Technological Advancements: Ongoing technological innovations have opened new avenues for extracting miRNA sequences efficiently, enhancing the overall market prospects.

3. Interest in miRNA Biomarker Identification: The growing interest in identifying miRNA biomarkers for various medical conditions is driving demand in the miRNA sequencing and testing sector.

4. Rising Neurological Illnesses: With an uptick in neurological disorders, the demand for personalized treatments and precise diagnostics has driven the growth of this market segment.

North America Dominates the Market

North America is expected to offer the largest opportunity for the miRNA Sequencing and Assay Market, accounting for over 4% of the market share throughout the forecasted period. The region's dominance can be attributed to the presence of prominent firms like Illumina Inc., PerkinElmer, Inc., and Thermo Fisher Scientific, which have significantly increased their R&D expenditure to develop novel solutions. Illumina, Inc., for instance, allocated US$ 682 million for research and development in 2020, underscoring its commitment to advancing sequence analysis technologies.

Asia Pacific Emerges as the Fastest-Growing Region

The Asia Pacific region is projected to witness the fastest growth in the miRNA Sequencing and Assay Market throughout the forecast period. This growth can be attributed to the presence of organizations such as APBioNet, which actively supports and educates researchers in the field. APBioNet plays a pivotal role in tracking the development of bioinformatics infrastructure, facilitating data sharing, and hosting training programs, seminars, and conferences, thus driving the rapid growth of the miRNA Sequencing and Assay Market in the region.

Covid-19 Impact on the Market

The Covid-19 pandemic brought new insights into the miRNA Sequencing and Assay Market as researchers discovered the interaction between SARS-CoV-2 RNA sequences and human MicroRNAs during vaccine development. This revelation highlighted the critical role of miRNAs in virus-host cell interactions. As a result, the market saw increased interest in understanding how host miRNAs influence SARS-CoV-2 infection.

Country-wise Analysis

U.S. miRNA Sequencing and Assay Market Analysis

The United States is poised to dominate the miRNA Sequencing and Assay Market, holding the highest market share by the end of 2031. The growth in this market can be attributed to increased investments in sequencing development, expanding research efforts in the fields of Genomics and RNA biology, and a growing demand for cost-effective, high-throughput approaches for miRNA analysis.

U.K. miRNA Sequencing and Assay Market Analysis

The miRNA Sequencing and Assay Market in the United Kingdom (U.K.) is on a trajectory to reach a substantial valuation in 2031, having grown significantly from its 2024 figure. During the forecast period, the market is expected to present a noteworthy dollar opportunity, highlighting its potential for substantial growth.

Japan miRNA Sequencing and Assay Market Analysis

Japan is witnessing substantial growth in its miRNA Sequencing and Assay Market, with an expected increase in valuation from 2023. With a promising compound annual growth rate (CAGR), the Japanese market is set to offer a considerable absolute dollar opportunity during the forecast period, indicating a robust growth trajectory.

South Korea miRNA Sequencing and Assay Market Analysis

The miRNA Sequencing and Assay Market in South Korea is experiencing significant expansion, with a notable rise in valuation since 2023. This market is projected to maintain its growth momentum with a respectable CAGR, offering a substantial absolute dollar opportunity during the forecast period, reflecting its potential for sustained development.

Competitive Landscape

Key companies operating in the miRNA Sequencing and Assay Market include Thermo Fisher Scientific, Illumina, QIAGEN, PerkinElmer, Abcam plc, New England Biolabs, Takara Bio Inc., Lexogen GmbH, Norgen Biotek Corp, Maravai LifeSciences, HTG Molecular Diagnostics, Meridian Bioscience, Inc., and System Biosciences, LLC. These industry leaders continue to drive innovation and shape the future of miRNA sequencing and assays.

Market Segments Covered in miRNA Sequencing and Assay Market Analysis

By Component
• Products
Library Preparation Kits
Sequencing Consumables
Instruments
• Services

By Technology
• Sequencing by Synthesis
• Seq. by Oligonucleotide Ligation and Detection (SOLiD)
• Nanopore Seq.
• Sanger Seq.
• Single Molecule Real-time (SMRT) Seq.

By Workflow
• Library Preparation
• Sequencing
• Data Analysis & Storage

By Application
• Cancer
• Polyglutamine Diseases
• Autoimmune Disease
• Schizophrenia
• Other Applications

By Region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global miRNA Sequencing and Assay Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global miRNA Sequencing and Assay Market Outlook, 2018 – 2031
3.1. Global miRNA Sequencing and Assay Market Outlook, by Component, Value (US$ Mn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Products
3.1.1.1.1. Library Preparation Kits
3.1.1.1.2. Sequencing Consumables
3.1.1.1.3. Instruments
3.1.1.2. Services
3.2. Global miRNA Sequencing and Assay Market Outlook, by Technology, Value (US$ Mn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Sequencing by Synthesis
3.2.1.2. Seq. by Oligonucleotide Ligation and Detection (SOLiD)
3.2.1.3. Nanopore Seq.
3.2.1.4. Sanger Seq.
3.2.1.5. Single Molecule Real-time (SMRT) Seq.
3.3. Global miRNA Sequencing and Assay Market Outlook, by Workflow, Value (US$ Mn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Library Preparation
3.3.1.2. Sequencing
3.3.1.3. Data Analysis & Storage
3.4. Global miRNA Sequencing and Assay Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. Cancer
3.4.1.2. Polyglutamine Diseases
3.4.1.3. Autoimmune Disease
3.4.1.4. Schizophrenia
3.4.1.5. Other Applications
3.5. Global miRNA Sequencing and Assay Market Outlook, by Region, Value (US$ Mn), 2018 – 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America miRNA Sequencing and Assay Market Outlook, 2018 – 2031
4.1. North America miRNA Sequencing and Assay Market Outlook, by Component, Value (US$ Mn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Products
4.1.1.1.1. Library Preparation Kits
4.1.1.1.2. Sequencing Consumables
4.1.1.1.3. Instruments
4.1.1.2. Services
4.2. North America miRNA Sequencing and Assay Market Outlook, by Technology, Value (US$ Mn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Sequencing by Synthesis
4.2.1.2. Seq. by Oligonucleotide Ligation and Detection (SOLiD)
4.2.1.3. Nanopore Seq.
4.2.1.4. Sanger Seq.
4.2.1.5. Single Molecule Real-time (SMRT) Seq.
4.3. North America miRNA Sequencing and Assay Market Outlook, by Workflow, Value (US$ Mn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Library Preparation
4.3.1.2. Sequencing
4.3.1.3. Data Analysis & Storage
4.4. North America miRNA Sequencing and Assay Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. Cancer
4.4.1.2. Polyglutamine Diseases
4.4.1.3. Autoimmune Disease
4.4.1.4. Schizophrenia
4.4.1.5. Other Applications
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America miRNA Sequencing and Assay Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
4.5.1. Key Highlights
4.5.1.1. U.S. miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
4.5.1.2. U.S. miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
4.5.1.3. U.S. miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
4.5.1.4. U.S. miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
4.5.1.5. Canada miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
4.5.1.6. Canada miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
4.5.1.7. Canada miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
4.5.1.8. Canada miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe miRNA Sequencing and Assay Market Outlook, 2018 – 2031
5.1. Europe miRNA Sequencing and Assay Market Outlook, by Component, Value (US$ Mn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Products
5.1.1.1.1. Library Preparation Kits
5.1.1.1.2. Sequencing Consumables
5.1.1.1.3. Instruments
5.1.1.2. Services
5.2. Europe miRNA Sequencing and Assay Market Outlook, by Technology, Value (US$ Mn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Sequencing by Synthesis
5.2.1.2. Seq. by Oligonucleotide Ligation and Detection (SOLiD)
5.2.1.3. Nanopore Seq.
5.2.1.4. Sanger Seq.
5.2.1.5. Single Molecule Real-time (SMRT) Seq.
5.3. Europe miRNA Sequencing and Assay Market Outlook, by Workflow, Value (US$ Mn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Library Preparation
5.3.1.2. Sequencing
5.3.1.3. Data Analysis & Storage
5.4. Europe miRNA Sequencing and Assay Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Cancer
5.4.1.2. Polyglutamine Diseases
5.4.1.3. Autoimmune Disease
5.4.1.4. Schizophrenia
5.4.1.5. Other Applications
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe miRNA Sequencing and Assay Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
5.5.1. Key Highlights
5.5.1.1. Germany miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
5.5.1.2. Germany miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
5.5.1.3. Germany miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
5.5.1.4. Germany miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
5.5.1.5. U.K. miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
5.5.1.6. U.K. miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
5.5.1.7. U.K. miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
5.5.1.8. U.K. miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
5.5.1.9. France miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
5.5.1.10. France miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
5.5.1.11. France miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
5.5.1.12. France miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
5.5.1.13. Italy miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
5.5.1.14. Italy miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
5.5.1.15. Italy miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
5.5.1.16. Italy miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
5.5.1.17. Turkey miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
5.5.1.18. Turkey miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
5.5.1.19. Turkey miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
5.5.1.20. Turkey miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
5.5.1.21. Russia miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
5.5.1.22. Russia miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
5.5.1.23. Russia miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
5.5.1.24. Russia miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
5.5.1.25. Rest of Europe miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
5.5.1.26. Rest of Europe miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
5.5.1.27. Rest of Europe miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
5.5.1.28. Rest of Europe miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific miRNA Sequencing and Assay Market Outlook, 2018 – 2031
6.1. Asia Pacific miRNA Sequencing and Assay Market Outlook, by Component, Value (US$ Mn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Products
6.1.1.1.1. Library Preparation Kits
6.1.1.1.2. Sequencing Consumables
6.1.1.1.3. Instruments
6.1.1.2. Services
6.2. Asia Pacific miRNA Sequencing and Assay Market Outlook, by Technology, Value (US$ Mn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Sequencing by Synthesis
6.2.1.2. Seq. by Oligonucleotide Ligation and Detection (SOLiD)
6.2.1.3. Nanopore Seq.
6.2.1.4. Sanger Seq.
6.2.1.5. Single Molecule Real-time (SMRT) Seq.
6.3. Asia Pacific miRNA Sequencing and Assay Market Outlook, by Workflow, Value (US$ Mn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Library Preparation
6.3.1.2. Sequencing
6.3.1.3. Data Analysis & Storage
6.4. Asia Pacific miRNA Sequencing and Assay Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. Cancer
6.4.1.2. Polyglutamine Diseases
6.4.1.3. Autoimmune Disease
6.4.1.4. Schizophrenia
6.4.1.5. Other Applications
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific miRNA Sequencing and Assay Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
6.5.1. Key Highlights
6.5.1.1. China miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
6.5.1.2. China miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
6.5.1.3. China miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
6.5.1.4. China miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
6.5.1.5. Japan miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
6.5.1.6. Japan miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
6.5.1.7. Japan miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
6.5.1.8. Japan miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
6.5.1.9. South Korea miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
6.5.1.10. South Korea miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
6.5.1.11. South Korea miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
6.5.1.12. South Korea miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
6.5.1.13. India miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
6.5.1.14. India miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
6.5.1.15. India miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
6.5.1.16. India miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
6.5.1.17. Southeast Asia miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
6.5.1.18. Southeast Asia miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
6.5.1.19. Southeast Asia miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
6.5.1.20. Southeast Asia miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
6.5.1.21. Rest of Asia Pacific miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
6.5.1.22. Rest of Asia Pacific miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
6.5.1.23. Rest of Asia Pacific miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
6.5.1.24. Rest of Asia Pacific miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America miRNA Sequencing and Assay Market Outlook, 2018 – 2031
7.1. Latin America miRNA Sequencing and Assay Market Outlook, by Component, Value (US$ Mn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Products
7.1.1.1.1. Library Preparation Kits
7.1.1.1.2. Sequencing Consumables
7.1.1.1.3. Instruments
7.1.1.2. Services
7.2. Latin America miRNA Sequencing and Assay Market Outlook, by Technology, Value (US$ Mn), 2018 – 2031
7.2.1.1. Sequencing by Synthesis
7.2.1.2. Seq. by Oligonucleotide Ligation and Detection (SOLiD)
7.2.1.3. Nanopore Seq.
7.2.1.4. Sanger Seq.
7.2.1.5. Single Molecule Real-time (SMRT) Seq.
7.3. Latin America miRNA Sequencing and Assay Market Outlook, by Workflow, Value (US$ Mn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Library Preparation
7.3.1.2. Sequencing
7.3.1.3. Data Analysis & Storage
7.4. Latin America miRNA Sequencing and Assay Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Cancer
7.4.1.2. Polyglutamine Diseases
7.4.1.3. Autoimmune Disease
7.4.1.4. Schizophrenia
7.4.1.5. Other Applications
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America miRNA Sequencing and Assay Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
7.5.1. Key Highlights
7.5.1.1. Brazil miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
7.5.1.2. Brazil miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
7.5.1.3. Brazil miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
7.5.1.4. Brazil miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
7.5.1.5. Mexico miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
7.5.1.6. Mexico miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
7.5.1.7. Mexico miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
7.5.1.8. Mexico miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
7.5.1.9. Argentina miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
7.5.1.10. Argentina miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
7.5.1.11. Argentina miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
7.5.1.12. Argentina miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
7.5.1.13. Rest of Latin America miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
7.5.1.14. Rest of Latin America miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
7.5.1.15. Rest of Latin America miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
7.5.1.16. Rest of Latin America miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa miRNA Sequencing and Assay Market Outlook, 2018 – 2031
8.1. Middle East & Africa miRNA Sequencing and Assay Market Outlook, by Component, Value (US$ Mn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Products
8.1.1.1.1. Library Preparation Kits
8.1.1.1.2. Sequencing Consumables
8.1.1.1.3. Instruments
8.1.1.2. Services
8.2. Middle East & Africa miRNA Sequencing and Assay Market Outlook, by Technology, Value (US$ Mn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Sequencing by Synthesis
8.2.1.2. Seq. by Oligonucleotide Ligation and Detection (SOLiD)
8.2.1.3. Nanopore Seq.
8.2.1.4. Sanger Seq.
8.2.1.5. Single Molecule Real-time (SMRT) Seq.
8.3. Middle East & Africa miRNA Sequencing and Assay Market Outlook, by Workflow, Value (US$ Mn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Library Preparation
8.3.1.2. Sequencing
8.3.1.3. Data Analysis & Storage
8.4. Middle East & Africa miRNA Sequencing and Assay Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. Cancer
8.4.1.2. Polyglutamine Diseases
8.4.1.3. Autoimmune Disease
8.4.1.4. Schizophrenia
8.4.1.5. Other Applications
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa miRNA Sequencing and Assay Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
8.5.1. Key Highlights
8.5.1.1. GCC miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
8.5.1.2. GCC miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
8.5.1.3. GCC miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
8.5.1.4. GCC miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
8.5.1.5. South Africa miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
8.5.1.6. South Africa miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
8.5.1.7. South Africa miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
8.5.1.8. South Africa miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
8.5.1.9. Egypt miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
8.5.1.10. Egypt miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
8.5.1.11. Egypt miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
8.5.1.12. Egypt miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
8.5.1.13. Nigeria miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
8.5.1.14. Nigeria miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
8.5.1.15. Nigeria miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
8.5.1.16. Nigeria miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
8.5.1.17. Rest of Middle East & Africa miRNA Sequencing and Assay Market by Component, Value (US$ Mn), 2018 – 2031
8.5.1.18. Rest of Middle East & Africa miRNA Sequencing and Assay Market by Technology, Value (US$ Mn), 2018 – 2031
8.5.1.19. Rest of Middle East & Africa miRNA Sequencing and Assay Market by Workflow, Value (US$ Mn), 2018 – 2031
8.5.1.20. Rest of Middle East & Africa miRNA Sequencing and Assay Market by Application, Value (US$ Mn), 2018 – 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Application Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Thermo Fisher Scientific
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Illumina
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. QIAGEN
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. PerkinElmer
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Abcam plc
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. New England Biolabs
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Takara Bio Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Lexogen GmbH
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Norgen Biotek Corp
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings